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Pulmonary mucormycosis is a relatively uncommon infection. It can present in various forms. Very few
cases of pulmonary mucormycosis presenting as vocal cord paralysis have been described in the liter-
ature. We report a case of pulmonary mucormycosis presenting as vocal cord paralysis in an uncontrolled
diabetic patient.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Pulmonary mucormycosis is an opportunistic infection occur-
ring in immunocompromised conditions. Pulmonary mucormy-
cosis can present as solitary nodule, pneumonia, cavitary lesion or
in disseminated form. Endobronchial mucormycosis presenting as
vocal cord paralysis has been reported earlier.1 We report a case of
pulmonary mucormycosis presenting with hoarseness due to vocal
cord palsy.2. Case report
A 52-year male patient presented with fever and cough of 1
month duration. He also had hoarseness of voice and haemoptysis
of 2 weeks duration. Known case of uncontrolled Diabetes on oral
hypoglycemic drugs from a general practitioner. He was a chronic
smoker with 20 pack years. There was no history of tuberculosis in
the past. Hewas treated with broad spectrum antibiotics elsewhere
before presenting to our hospital.
On examination, his vitals were stable. He had slightly
decreased air entry in the left infrascapular region. Cardiovascular
examination and Abdomen was normal. His blood investigations
revealed anaemia, leucocytosis and raised erythrocyte sedimenta-
tion rate. His Haemoglobin A1c was 9.3. Sputum for Acid fast bacilli,
Fungal elements and malignant cells were negative. His HIV status
was negative.
Chest x-ray revealed left perihilar opacity and left lower zone
opacity suggestive of consolidation [Fig. 1]. CT scan of the Thoraxbile).
ayathri Devi).
-NC-ND license.showed peribronchial lesion on left side with considerable nar-
rowing of the left main bronchus with inﬁltrates in the lower lobe
[Fig. 2]. Fibreoptic video laryngoscopy showed left vocal cord palsy.
Mucosa appeared normal without any lesions. MRI of the Neck was
done to look for local lesion for vocal cord paralysis and it was
normal. Bronchoscopy was done with a presumptive diagnosis of
bronchogenic carcinoma. Bronchoscopy revealed left vocal cord
paralysis and extrinsic narrowing of the left main bronchus. How-
ever scope could be passed beyond the narrowing. There was
mucosal thickening at the secondary carina. Transbronchial biopsy
was taken from the left lower lobe bronchus which showed
considerable narrowing as shown in the image [Fig. 3]. Histopa-
thology examination revealed fungal hyphae in the subepithelial
tissue suggestive of mucormycosis [Fig. 4A and B].
He was started on lipid complex Amphotericin B instead of
liposomal amphotericin because of ﬁnancial constraints. His renal
status and electrolytes were closely monitored while on treatment.
He was discharged at request after 2 weeks of treatment.
Subsequent follow up CT of the Thorax revealed considerable
reduction in the size of the left perihilar opacity [Fig. 5]. There was
no mediastinal or hilar lymphadenopathy. He was advised repeat
bronchoscopy, which he declined.3. Discussion
Mucormycosis term refers to infections caused by fungi of the
order Mucorales.2 These are opportunistic infections seen in
immunocompromised conditions like Diabetes Mellitus, stem cell
transplant patients, haematological malignancy and solid organ
transplant patients.3 Pulmonary mucormycosis is the second most
common form of mucormycosis, ﬁrst being Rhinocerebral form.4
Fig. 1. Chest X-ray PA showing left perihilar and lower zone opacity.
Fig. 3. Bronchoscopy showing narrowing of left lower lobe bronchus.
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tions are also seen.5
Pulmonary mucormycosis is a relatively uncommon opportu-
nistic fungal infection with high mortality rate. Mucormycosis is
reported most commonly in diabetic patients.6 Diwaker A et all
have done an analysis of themucormycosis cases in India and found
that uncontrolled diabetes was the most common risk factor in
India.7 Pulmonary mucormycosis presents with cough, haemopt-
ysis, fever, dyspnoea and chest pain. Pulmonary mucormycosis can
present as pneumonia, solitary nodule, cavitary lesion or in
disseminated form. It can also present as endobronchial polypoid
lesion.8
Very few cases of pulmonary mucormycosis presenting as vocal
cord palsy have been described in the literature. V. Suresh et all
have reported a case of recurrent laryngeal nerve palsy due to
pulmonary mucormycosis.1 Left vocal cord palsy in our patient is
suggestive of left recurrent laryngeal nerve involvement. LeftFig. 2. CT Thorax showing peribronchial lesion on left side with considerablerecurrent laryngeal nerve is closely apposed to the tracheo-
oesophageal groove.1 Mucormycosis has angioinvasive properties
which can cause thrombosis leading to necrosis of the tissue. In-
vasion of the bronchial wall in the histopathology image is sug-
gestive of the possibility of involvement of the recurrent laryngeal
nerve by the necrotizing lesion due to mucormycosis.
Therapy involves systemic antifungal therapy, surgical resection
and control of the underlying disease whenever possible.9
Amphotericin B Deoxycholate is the only licenced agent fornarrowing of the left main bronchus with inﬁltrates in the lower lobe.
Fig. 5. CT Thorax post-treatment showing reduction in the peribronchial lesion.
Fig. 4. Photomicrograph showing broad non-septate non-branching hyphae suggestive of mucormycosis, (PAS, 400).
H.J. Gayathri Devi et al. / Respiratory Medicine Case Reports 9 (2013) 15e17 17treating mucormycosis. Lipid formulations of Amphotericin B are
Amphotericin B lipid complex and liposomal Amphotericin Bwhich
are less nephrotoxic and safer to use. Posaconazole is useful as
salvage therapy. Antifungal therapy should be given until there is
clinical and radiological evidence of resolution of infection.4
Prompt and effective therapy are essential for a successful outcome.4. Conclusion
In conclusion, it is important to consider unusual manifestations
of mucormycosis for an early diagnosis in immunocompromised
conditions.
Early diagnosis and prompt institution of appropriate antifungal
treatment can bring down the mortality due to mucormycosis.Source of support
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